vimarsana.com
Home
Live Updates
ORYZON Reports Financial Results and Corporate Updates for Quarter Ended September 30, 2023 : vimarsana.com
ORYZON Reports Financial Results and Corporate Updates for Quarter Ended September 30, 2023 : vimarsana.com
ORYZON Reports Financial Results and Corporate Updates for Quarter Ended September 30, 2023
27.10.2023 - Positive aggregate safety data from vafidemstat's fully enrolled PORTICO Phase IIb trial in Borderline Personality Disorder (BPD), consistent with safety data from seven completed clinical trials, supporting the drug is safe and ...
Related Keywords
San Diego ,
California ,
United States ,
Boston ,
Massachusetts ,
Spain ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Buesa ,
Comunidad Autonoma De Aragon ,
Barcelona ,
Comunidad Autonoma De Cataluna ,
Spanish ,
Ashleyr Robinson ,
Patricia Cobo Daniel Foley ,
Teaes Steaes ,
Lifesci Advisors ,
Us National Cancer Institute ,
European College Of Neuropsychopharmacology ,
Research Convention In Cambridge ,
Research Foundation ,
Exchange Euro Dollar ,
Research Convention ,
Spanish Ministry Of Science ,
Development Agreement ,
Drug Administration ,
Fox Chase Cancer Center ,
Third Annual Global ,
European College ,
Spanish Ministry ,
Kabuki Syndrome ,
Acute Myeloid Leukemia ,
Recommended Phase ,
Measurable Residual Disease ,
Lateral Sclerosis ,
Third Quarter ,
Cancer Cell ,
Fim Phase ,
Cooperative Research ,
Cancer Institute ,
Secondary Progressive ,
Spanish Comisi ,
Nacional Del Mercado De Valores ,
Sci Advisors ,